Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed director
Quarterly results
|
|
ENANTA PHARMACEUTICALS INC (ENTA)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 04/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/17/2023 |
4
| Vance Terry (Director) has filed a Form 4 on ENANTA PHARMACEUTICALS INC|
Txns:
| Exercised 5,800 options to buy
@ $14, valued at
$81.2k
|
|
| 03/17/2023 |
4
| MELLETT PAUL J (Treasurer and CFO) has filed a Form 4 on ENANTA PHARMACEUTICALS INC|
Txns:
| Sold 100 shares
@ $43.96, valued at
$4.4k
Sold 10,340 shares
@ $44.43, valued at
$459.4k
Exercised 10,440 options to buy
@ $14, valued at
$146.2k
|
|
| 03/17/2023 |
4
| Or Yat Sun (Sr. VP & CSO) has filed a Form 4 on ENANTA PHARMACEUTICALS INC|
Txns:
| Sold 269 shares
@ $43.92, valued at
$11.8k
Sold 13,656 shares
@ $44.46, valued at
$607.1k
Exercised 13,925 options to buy
@ $14, valued at
$195k
|
|
| 03/14/2023 |
4
| Luly Jay R. (President and CEO) has filed a Form 4 on ENANTA PHARMACEUTICALS INC|
Txns:
| Sold 10,697 shares
@ $44.81, valued at
$479.3k
Sold 15,649 shares
@ $45.31, valued at
$709.1k
Sold 1,566 shares
@ $46.13, valued at
$72.2k
Exercised 27,912 options to buy
@ $14, valued at
$390.8k
|
|
| 03/06/2023 |
4
| Vance Terry (Director) has filed a Form 4 on ENANTA PHARMACEUTICALS INC|
Txns:
| Granted 10,800 options to buy
@ $47.72, valued at
$515.4k
|
|
| 03/06/2023 |
4
| Russell Lesley (Director) has filed a Form 4 on ENANTA PHARMACEUTICALS INC|
Txns:
| Granted 10,800 options to buy
@ $47.72, valued at
$515.4k
|
|
| 03/06/2023 |
4
| Peterson Kristine (Director) has filed a Form 4 on ENANTA PHARMACEUTICALS INC|
Txns:
| Granted 10,800 options to buy
@ $47.72, valued at
$515.4k
|
|
| 03/06/2023 |
4
| Hata Yujiro S (Director) has filed a Form 4 on ENANTA PHARMACEUTICALS INC|
Txns:
| Granted 10,800 options to buy
@ $47.72, valued at
$515.4k
|
|
| 03/06/2023 |
4
| FOLETTA MARK G (Director) has filed a Form 4 on ENANTA PHARMACEUTICALS INC|
Txns:
| Granted 10,800 options to buy
@ $47.72, valued at
$515.4k
|
|
| 03/06/2023 |
4
| CARTER BRUCE L A (Director) has filed a Form 4 on ENANTA PHARMACEUTICALS INC|
Txns:
| Granted 10,800 options to buy
@ $47.72, valued at
$515.4k
|
|
| 02/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/11/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2022 |
4
| MELLETT PAUL J (Treasurer and CFO) has filed a Form 4 on ENANTA PHARMACEUTICALS INC|
Txns:
| Exercised 3,480 options to buy
@ $11.77, valued at
$41k
|
|
| 04/05/2022 |
4
| Adda Nathalie (Sr. VP & Chief Medical Officer) has filed a Form 4 on ENANTA PHARMACEUTICALS INC|
Txns:
| Sold 8,299 shares
@ $70.75, valued at
$587.2k
Sold 42,260 shares
@ $71.32, valued at
$3M
Sold 2,500 shares
@ $70.56, valued at
$176.4k
Sold 18,076 shares
@ $71.71, valued at
$1.3M
Sold 3,200 shares
@ $72.65, valued at
$232.5k
Sold 9,009 shares
@ $73.42, valued at
$661.4k
Exercised 16,000 options to buy
@ $31.42, valued at
$502.7k
Exercised 31,664 options to buy
@ $30, valued at
$949.9k
Exercised 2,895 options to buy
@ $48.52, valued at
$140.5k
Exercised 6,285 options to buy
@ $48.52, valued at
$304.9k
Exercised 9,625 options to buy
@ $43.57, valued at
$419.4k
|
|
| 03/22/2022 |
4
| CARTER BRUCE L A (Director) has filed a Form 4 on ENANTA PHARMACEUTICALS INC|
Txns:
| Sold 2,676 shares
@ $66.7, valued at
$178.5k
Sold 307 shares
@ $67.23, valued at
$20.6k
Sold 2,210 shares
@ $68.66, valued at
$151.7k
Sold 807 shares
@ $69.52, valued at
$56.1k
Exercised 6,000 options to buy
@ $25.58, valued at
$153.5k
|
|
| 03/07/2022 |
4
| Vance Terry (Director) has filed a Form 4 on ENANTA PHARMACEUTICALS INC|
Txns:
| Granted 7,500 options to buy
@ $68.22, valued at
$511.7k
|
|
|
|
|